Close Menu

NEW YORK (GenomeWeb) – Foundation Medicine said this week that it quickly resolved an issue regarding reporting of tumor mutational burden (TMB) by its FoundationOne CDx test that had surfaced in October.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.